Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen is filled with slightly more tirzepatide than the four weekly doses it delivers. That small surplus is a manufacturing overfill, not a fifth dose you can retrieve. Understanding this helps you use your pen correctly, avoid waste, and know when something genuinely looks wrong. Mounjaro is a prescription-only medicine; the right way to use any given pen or dose is set by your prescriber and the patient information leaflet, not by how much liquid you can see through the window.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's one of the most common observations patients share: they press the button for their fourth dose, cap the pen, and then notice the viewing window still shows a sliver of liquid. The instinctive read is that something was wasted, or that there is a hidden fifth injection sitting there unused.
There isn't. Eli Lilly fills each KwikPen with a small volume of tirzepatide beyond what the four dose counters will release. This overfill compensates for dead space in the needle hub, the mechanics of the dosing mechanism, and the small amount of solution that coats the inside of the reservoir. It is an industry-standard practice for this class of pre-filled auto-injector, not a Mounjaro quirk. The NHS tirzepatide medicines page and the full Summary of Product Characteristics both describe the pen as delivering four doses only, the printed dose counter is the authoritative guide, not the liquid level.
Once the counter reaches zero and the button locks, the pen has given what it was designed to give. The remaining liquid is not accessible in a clinically safe or metrically accurate way. Dispose of the pen in a suitable sharps container and start a fresh pen for your next injection.
A misconception that circulates in online weight-loss communities is that drawing residual liquid from a finished pen with a syringe gives you a usable dose. It does not, for several reasons that matter clinically.
First, the volume remaining after four doses is less than a full injection's worth; the counter stops before the pen is literally empty precisely because the tail end of the reservoir cannot be reliably expelled through the pen mechanism. Second, opening the pen or inserting a syringe needle directly into the cartridge creates contamination risk and voids any quality assurance. Third, you have no reliable way to measure what you have drawn, tirzepatide dosing is precise, and fractions of a milligram in either direction are not trivial. Our detailed page on extracting Mounjaro from the pen covers exactly why this is not a recommended approach and what clinical guidance says.
If the concern driving this is the cost of treatment, that is entirely understandable. There is honest information about what Mounjaro costs privately in the UK that may help you plan.
This is a different situation and worth taking seriously. If the dose counter reaches zero earlier than expected, or the pen mechanism sticks or fails mid-injection, do not attempt a second pen for the same weekly dose without speaking to a clinician first. What to do when Mounjaro is left in a pen after a partial or interrupted injection is covered in more detail separately, but the short answer is the same: contact your prescriber or the pharmacy that dispensed the medicine.
Pen faults are uncommon but they do occur. The correct route is to report the issue, note the batch number printed on the pen, and get clinical advice before your next scheduled injection. Do not try to make up a dose from a second pen without guidance. Our prescribers are available seven days a week through our aftercare service, reach out via the contact page and a clinician will advise you.
For broader questions about how the pen itself works, the tirzepatide pre-filled pen guide explains the mechanism, the viewing window, and what a correctly completed injection looks like.
Yes, and this is worth knowing. Every injection should use a fresh needle, not because the old one is blunt (though it is), but because a used needle develops microscopic burrs and dried medication in the hub that can affect flow and, in some cases, mean a small amount of solution remains in the needle rather than being delivered into tissue. This is one reason the overfill exists: to account for needle dead space.
Always attach a new needle before each injection, inject the dose fully, and hold the button down for the count recommended in the leaflet before withdrawing. If you need to stock up between deliveries, you can order extra Mounjaro needles so you are never left short before an injection. For needles compatible with the Mounjaro KwikPen, replacement pen needles are available. The full step-by-step process (including how to prime a needle and rotate injection sites) is covered in the how to use the Mounjaro pen guide.
Proper injection technique is one of those things that sounds obvious until you realise how many small steps matter. A question our prescribers hear regularly is whether leftover liquid means a dose was missed. In most cases, it means the pen is working exactly as intended. If you are unsure after reading this, starting a free consultation with our clinical team is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.